FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

22672811000001106: Lansoprazole 15mg orodispersible tablets (Alliance Healthcare (Distribution) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 24-Jul 2013. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
74520001000001110 Lansoprazole 15mg orodispersible tablets (Alliance Healthcare (Distribution) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
74520101000001111 Lansoprazole 15mg orodispersible tablets (Alliance Healthcare (Distribution) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lansoprazole 15mg orodispersible tablets (Alliance Healthcare (Distribution) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Lansoprazole 15mg orodispersible tablets (Alliance Healthcare (Distribution) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lansoprazole 15mg orodispersible tablets (Alliance Healthcare (Distribution) Ltd) Is a Lansoprazole 15mg orodispersible gastro-resistant tablets true Inferred relationship Existential restriction modifier
Lansoprazole 15mg orodispersible tablets (Alliance Healthcare (Distribution) Ltd) Has active ingredient Lansoprazole true Inferred relationship Existential restriction modifier
Lansoprazole 15mg orodispersible tablets (Alliance Healthcare (Distribution) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lansoprazole 15mg orodispersible tablets (Alliance Healthcare (Distribution) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Lansoprazole 15mg orodispersible tablets (Alliance Healthcare (Distribution) Ltd) Has specific active ingredient Lansoprazole true Inferred relationship Existential restriction modifier
Lansoprazole 15mg orodispersible tablets (Alliance Healthcare (Distribution) Ltd) Has dispensed dose form Conventional release orodispersible tablet true Inferred relationship Existential restriction modifier
Lansoprazole 15mg orodispersible tablets (Alliance Healthcare (Distribution) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Lansoprazole 15mg orodispersible tablets (Alliance Healthcare (Distribution) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Lansoprazole 15mg orodispersible tablets (Alliance Healthcare (Distribution) Ltd) Has manufactured dose form Conventional release orodispersible tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Lansoprazole 15mg orodispersible tablets (Alliance Healthcare (Distribution) Ltd) 28 tablet Has AMP True Lansoprazole 15mg orodispersible tablets (Alliance Healthcare (Distribution) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start